Milestone payment triggered by European Medicines Agency acceptance of marketing authorization application for rezafungin
Company eligible to receive up to an additional $108M in milestones from multiple existing partnerships based on successful completion of activities planned for the next two years
https://finance.yahoo.com/news/cidara-therapeutics-receives-11-1-120000785.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.